Causes and Mechanism of Duchenne Muscular Dystrophy
Duchenne muscular dystrophy (DMD) is a genetic disorder characterized by progressive muscle degeneration and weakness. It is caused by the absence of dystrophin, a protein that helps keep muscle cells intact. The defective gene that causes DMD is located on the X chromosome, so it primarily affects boys. Girls can be carriers of the defective...
The global duchenne muscular dystrophy (dmd) treatment market size was valued at USD 3.8 billion in 2022 and is poised to grow at a significant CAGR of 38.2% during the forecast period 2023-29. It also includes market size and projection estimations for each of the five major regions from 2023 to 2029. The research report includes historical data, trending features, and market growth...
The global Duchenne Muscular Dystrophy (DMD) Treatment Market is estimated to be valued at US$2,787.6 million in 2022 and is expected to exhibit a CAGR of 47.85% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.A) Market Overview:Duchenne Muscular Dystrophy is a rare genetic disorder that primarily affects males, leading to progressive...
Corticosteroid therapy is a cornerstone of Duchenne Muscular Dystrophy (DMD) treatment. These medications, such as prednisone and deflazacort, have shown significant benefits in slowing disease progression and prolonging ambulation in individuals with DMD. Corticosteroids work by reducing inflammation and suppressing muscle fiber damage, thus preserving muscle strength and function. However,...